These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 22341396

  • 21. Quantitative study of parathyroid hormone (1-34) and bone morphogenetic protein-2 on spinal fusion outcomes in a rabbit model of lumbar dorsolateral intertransverse process arthrodesis.
    Lina IA, Puvanesarajah V, Liauw JA, Lo SF, Santiago-Dieppa DR, Hwang L, Mao A, Bydon A, Wolinsky JP, Sciubba DM, Gokaslan Z, Holmes C, Witham TF.
    Spine (Phila Pa 1976); 2014 Mar 01; 39(5):347-55. PubMed ID: 24365898
    [Abstract] [Full Text] [Related]

  • 22. Effect of nano-hydroxyapatite/collagen composite and bone morphogenetic protein-2 on lumbar intertransverse fusion in rabbits.
    Sun TS, Guan K, Shi SS, Zhu B, Zheng YJ, Cui FZ, Zhang W, Liao SS.
    Chin J Traumatol; 2004 Feb 01; 7(1):18-24. PubMed ID: 14728813
    [Abstract] [Full Text] [Related]

  • 23. ISSLS prize winner: positron emission tomography and magnetic resonance imaging for monitoring interbody fusion with equine bone protein extract, recombinant human bone morphogenetic protein-2, and autograft.
    Foldager C, Bendtsen M, Zou X, Zou L, Olsen AK, Munk OL, Stødkilde-Jørgensen H, Bünger C.
    Spine (Phila Pa 1976); 2008 Dec 01; 33(25):2683-90. PubMed ID: 19002076
    [Abstract] [Full Text] [Related]

  • 24. rhBMP-2 not alendronate combined with HA-TCP biomaterial and distraction osteogenesis enhance bone formation.
    Ni M, Li G, Tang PF, Chan KM, Wang Y.
    Arch Orthop Trauma Surg; 2011 Nov 01; 131(11):1469-76. PubMed ID: 21805359
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Growth of new bone guided by implants in a murine calvarial model.
    Freilich M, M Patel C, Wei M, Shafer D, Schleier P, Hortschansky P, Kompali R, Kuhn L.
    Bone; 2008 Oct 01; 43(4):781-8. PubMed ID: 18589010
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The in vivo biological effects of intradiscal recombinant human bone morphogenetic protein-2 on the injured intervertebral disc: an animal experiment.
    Huang KY, Yan JJ, Hsieh CC, Chang MS, Lin RM.
    Spine (Phila Pa 1976); 2007 May 15; 32(11):1174-80. PubMed ID: 17495773
    [Abstract] [Full Text] [Related]

  • 32. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.
    Slosar PJ, Josey R, Reynolds J.
    Spine J; 2007 May 15; 7(3):301-7. PubMed ID: 17482113
    [Abstract] [Full Text] [Related]

  • 33. The effect of bone morphogenic protein-2-coated tri-calcium phosphate/hydroxyapatite on new bone formation in a rat model of femoral distraction osteogenesis.
    Yang JH, Kim HJ, Kim SE, Yun YP, Bae JH, Kim SJ, Choi KH, Song HR.
    Cytotherapy; 2012 Mar 15; 14(3):315-26. PubMed ID: 22122301
    [Abstract] [Full Text] [Related]

  • 34. Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear.
    Glassman SD, Gum JL, Crawford CH, Shields CB, Carreon LY.
    Spine J; 2011 Jun 15; 11(6):522-6. PubMed ID: 20598649
    [Abstract] [Full Text] [Related]

  • 35. Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine.
    Burkus JK, Gornet MF, Glassman SD, Slosar PJ, Rosner MK, Deckey JE, Nowak J, Hatcher BM.
    Spine (Phila Pa 1976); 2011 Dec 01; 36(25):2158-67. PubMed ID: 21325990
    [Abstract] [Full Text] [Related]

  • 36. Novel Protamine-Based Polyelectrolyte Carrier Enhances Low-Dose rhBMP-2 in Posterolateral Spinal Fusion.
    Hu T, Abbah SA, Wang M, Toh SY, Lam RW, Naidu M, Bhakta G, Cool SM, Bhakoo K, Li J, Goh JC, Wong HK.
    Spine (Phila Pa 1976); 2015 May 01; 40(9):613-21. PubMed ID: 25705961
    [Abstract] [Full Text] [Related]

  • 37. Effect of recombinant human bone morphogenetic protein-2 on mandibular distraction at different rates in an experimental model.
    Cheung LK, Zheng LW.
    J Craniofac Surg; 2006 Jan 01; 17(1):100-8; discussion 109-10. PubMed ID: 16432416
    [Abstract] [Full Text] [Related]

  • 38. Early-term and mid-term histologic events during single-level posterolateral intertransverse process fusion with rhBMP-2/collagen carrier and a ceramic bulking agent in a nonhuman primate model: implications for bone graft preparation.
    Khan SN, Toth JM, Gupta K, Glassman SD, Gupta MC.
    J Spinal Disord Tech; 2014 Jun 01; 27(4):212-9. PubMed ID: 23073151
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of carriers of bone morphogenetic protein for spinal fusion.
    Minamide A, Kawakami M, Hashizume H, Sakata R, Tamaki T.
    Spine (Phila Pa 1976); 2001 Apr 15; 26(8):933-9. PubMed ID: 11317116
    [Abstract] [Full Text] [Related]

  • 40. The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects.
    Hong SJ, Kim CS, Han DK, Cho IH, Jung UW, Choi SH, Kim CK, Cho KS.
    Biomaterials; 2006 Jul 15; 27(20):3810-6. PubMed ID: 16574220
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.